HNSCC cell lines with the PIK3CA H1047R mutation were more vulnerable to the antiproliferative impact of alepelisib than were cell lines with the wild-type PIK3CA [98]. The gene discussed is PIK3CA; the disease is head and neck squamous cell carcinoma.